Supplementary Table 1 from Characterization of the Immunogenomic Landscape of Ovarian Cancer Uncovers a Distinct Subset of Endometroid Tumors Associated with High CST2 Expression and a Favorable Prognosis

James Boyle; Jan Maciej Zaucha; Felicia Ng; Andreas Spitzmüller; Miljenka Vuko; Felix J. Segerer; Monica Azqueta-Gavaldon; Marco Testori; Amelia Raymond; Barrett R. B. Nuttall; Andrea Ennio Storti; Sakshi Gulati; Shaan Gill; Michael J. Surace; Paola Marco‐Casanova; Emma V. Jones; Ben S. Sidders; Jorge Sergio Reis-Filho; Maurizio Scaltriti; Anita Semertzidou; Helen K. Angell

doi:10.1158/2767-9764.31168869

Supplementary Table 1 from Characterization of the Immunogenomic Landscape of Ovarian Cancer Uncovers a Distinct Subset of Endometroid Tumors Associated with High CST2 Expression and a Favorable Prognosis

2026 Open access

Read full text

Authors: James Boyle, Jan Maciej Zaucha, Felicia Ng, Andreas Spitzmüller, Miljenka Vuko, Felix J. Segerer, Monica Azqueta-Gavaldon, Marco Testori, Amelia Raymond, Barrett R. B. Nuttall, Andrea Ennio Storti, Sakshi Gulati

+9 more

Shaan Gill, Michael J. Surace, Paola Marco‐Casanova, Emma V. Jones, Ben S. Sidders, Jorge Sergio Reis-Filho, Maurizio Scaltriti, Anita Semertzidou, Helen K. Angell

DOI: 10.1158/2767-9764.31168869

Cited by: 0

Abstract

Patient demographics including age, histological subtype, grade, stage, radiation or platinum therapy, platinum resistance, HRD and BRCA status.

Fields of Study & Subjects

Ovarian cancer diagnosis and treatment Endometrial and Cervical Cancer Treatments BRCA gene mutations in cancer

Publication details

Publication date: 28 January 2026